Your browser doesn't support javascript.
loading
An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria.
Ho, Shu-Yein; Liu, Po-Hong; Hsu, Chia-Yang; Hsia, Cheng-Yuan; Su, Chien-Wei; Huang, Yi-Hsiang; Lei, Hao-Jan; He, Yi-Jhen; Hou, Ming-Chih; Huo, Teh-Ia.
Afiliação
  • Ho SY; Departments of Medicine.
  • Liu PH; Faculty of Medicine.
  • Hsu CY; Faculty of Medicine.
  • Hsia CY; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
  • Su CW; Faculty of Medicine.
  • Huang YH; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.
  • Lei HJ; Faculty of Medicine.
  • He YJ; Surgery.
  • Hou MC; Departments of Medicine.
  • Huo TI; Faculty of Medicine.
Am J Clin Oncol ; 42(9): 698-704, 2019 09.
Article em En | MEDLINE | ID: mdl-31335351

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bilirrubina / Albumina Sérica / Modelos Estatísticos / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bilirrubina / Albumina Sérica / Modelos Estatísticos / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2019 Tipo de documento: Article